Clinical Trial Update: A Study Comparing the Effectiveness and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus Placebo for the Treatment of Acute Pain From a Migraine Headache [Phase 4]

View source ↗

Summary

Phase 4 study comparing Ultracet (tramadol hydrochloride/acetaminophen) to placebo for acute migraine-related head pain; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache
• Migraine

Drugs mentioned

• ULTRACET (tramadol hydrochloride/acetaminophen)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Migraine, Head Pain | Phase 4 | Status: COMPLETED